• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
KEB
Click for more information
0.00% 0.0¢

KEB HANA BANK

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
KEB
Ann: Pricing Supplement 		23/11/18 0 262
23/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  262 
KEB
Ann: Note Deed Poll 		23/11/18 0 262
23/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  262 
KEB
Ann: Information Memorandum 		23/11/18 0 267
23/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  267 
KEB
Ann: Appendix 1B and Information Form & Checklist 		23/11/18 0 269
23/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  269 
KEB
Ann: ASX Market Release - Admission 		23/11/18 0 279
23/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  279 

See All Discussions arrow Created with Sketch.

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

What HotCopper users were watching; China outshines USA's Fed cut; Oz inflation CPI tracks downwards & more!
The winners & losers on market if negative gearing were gone Removing negative gearing would likely cause a seismic shift in investor behaviour. If that advantage were taken away, more investors might start eyeing the stock market...
ACCC seeks Olam divestments before it can buy Namoi Cotton Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
KalGold rolls out detailed aeromagnetic survey across Pinjin project Kalgoorlie Gold Mining Ltd has begun a high-resolution aeromagnetic geophysical survey across the northern parts of the Pinjin project
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.